DOI:
10.1055/s-00034915
Onkologische Welt
LinksClose Window
References
Mailankody S. et al
Orvacabtagene autoleucel (orva-cel), a B-cell maturation antigen-directed CAR T-cell therapy for patients with relapsed/refractory multiple myeloma: Update of the phase I/II EVOLVE study“.
ASCO 2020 Abstract 8504
Access:
We do not assume any responsibility for the contents of the web pages of other providers.